. . . . . . . . . . "bilimsel makale"@tr . . "\u0563\u056B\u057F\u0561\u056F\u0561\u0576 \u0570\u0578\u0564\u057E\u0561\u056E \u0570\u0580\u0561\u057F\u0561\u0580\u0561\u056F\u057E\u0561\u056E 2016 \u0569\u057E\u0561\u056F\u0561\u0576\u056B \u0583\u0565\u057F\u0580\u057E\u0561\u0580\u056B 8-\u056B\u0576"@hy . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?"@ast . . . . . . . . . . . . . . "Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?"@nl . . . . . . . . . "Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?"@en . . . . . . . . . . . . . "655-674" . . . . . . . . . . . . . . . . . . "article scientifique"@fr . . . . . . . . . . . . "5" . . . . . . "10.1517/14712598.2016.1152256" . . . . . . . . . . . . . "26855028" . . . . . . . . . . . . . . . . . . . . . "Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?"@en . . . . . . . . "Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?"@nl . "Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?"@ast . . . . . . . . . "article cient\u00EDfic"@ca . . . . . . . . . "Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?"@en . . . . "Joseph M Ryan" . . . . . . . . . . . . . . . . . "Adam J Adler" . . . . . . "16" . . . . . . . . . . . . . . . . . . . "vetenskaplig artikel"@sv . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en 2016"@ast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "articolo scientifico"@it . . . . . . . . . . . . . . . . . . . . . . . "\u0645\u0642\u0627\u0644\u0629 \u0639\u0644\u0645\u064A\u0629 \u0646\u0634\u0631\u062A \u0641\u064A 08 \u0641\u0628\u0631\u0627\u064A\u0631 2016"@ar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "wissenschaftlicher Artikel"@de . . . . . . . . . . . . . . "\u043D\u0430\u0443\u0447\u043D\u0438 \u0447\u043B\u0430\u043D\u0430\u043A"@sr . . . . . . . . "scientific article published on 08 February 2016"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?"@ast . . "wetenschappelijk artikel"@nl . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u043B\u044E\u0442\u043E\u043C\u0443 2016"@uk . . . . . . . . . . . . "Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?"@nl . . . . "vedeck\u00FD \u010Dl\u00E1nok"@sk . "4955764" . "Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "2016-02-08T00:00:00Z"^^ . . . "artigo cient\u00EDfico"@pt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Anthony T Vella" . . . . . . . . . . . . . "videnskabelig artikel"@da . . . . . . "Jeffrey S Wasser" . "v\u011Bdeck\u00FD \u010Dl\u00E1nek"@cs . . . . . . . . . . . . . . . . . . . . . . . . . . . .